Gene Query: CLMN

Dataset Description Geneva Score
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 73.8
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 73.8
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 59.64
The pioneer factor CEBPA modulates vitamin D signaling 59.64
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 57.96
RNA-sequencing of human liver tissue 55.19
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 50.33
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 41.28
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 39.85
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 37.93
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 37.93
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 31.36
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 31.31
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 30.57
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 29.63
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 29.63
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 28.78
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 27.5
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 27.33
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 26.46
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 25.69
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 25.69
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 25.09
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 25.08
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 24.76
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 24.57
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 23.77
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 23.64
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 23.42
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 23.42
Gene expression profiling associated with knockdown of LKB1 in human intrahepatic cholangiocarcinoma 23.35
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 23.06
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 22.26
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 22.21
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 22.21
Gene expression analysis of the impact of TDP-43 knockout in human cells. 21.99
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 21.96
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 21.19
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 21.15
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 20.84
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 20.51
RNA-seq of tumor cells following angiopellosis extravasation 20.38
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 20.1
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 20.08
Transcriptome analysis of human lung epithelial cells 18.91
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 18.82
Dtx3L and Androgen Signaling in Prostate Cancer 18.68
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 18.65
Genome-wide identification of cancer-specific alternative splicing in circRNA 18.02
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 17.98
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 17.98
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 17.96
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 17.96
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 17.84
TGF-β promotes genomic instability after loss of RUNX3 17.83
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 17.71
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 17.61
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 17.39
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 17.13
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 17.08
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 16.7
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 16.63
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 16.63
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 16.45
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 16.39
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 16.27
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 16.0
Role of COP1 on MAP kinase transcriptional output in melanoma 15.99
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 15.98
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 15.67
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 15.64
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 15.61
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 15.42
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 15.42
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 15.42
Chromatin landscape of human visceral and subcutaneous adipocytes 15.36
Genome wide expression change by RNF168 knocking down in MCF-7 cells 15.23
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 15.17
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 15.17
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 15.16
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 14.87
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 14.71
LncRNA-GAS5 negative regulation of YAP-target genes expression 14.67
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 14.64
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 14.53
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 14.52
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 14.52
Paxillin regulates genomic networks in prostate cancer [LNCaP] 14.39
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 14.39
Role for citron kinase in prostate cancer growth 14.35
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 14.34
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 14.2
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 14.2
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 14.17
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 14.16
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 14.16
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 14.13
CircRNAome diversity in human mature B-cells, T-cells and monocytes 14.11
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 14.06
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 14.06
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 14.05
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 14.05
Trascriptome of thyroid cancer-induced macrophages 13.97
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 13.91
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 13.86
A novel non-canonical signaling pathway mediates TGF-β1-induced glucocorticoid insensitivity in epithelial cells 13.85
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 13.48
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 13.45
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 13.45
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 13.43
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 13.32
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 13.27
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 13.11
RNA-sequencing 13.11
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 13.03
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 12.94
RNA-seq differential expression studies: more sequence, or more replication? 12.93
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 12.72
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 12.66
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 12.66
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 12.62
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 12.55
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 12.4
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 12.2
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 12.13
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 11.86
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 11.85
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 11.8
Global modulation of signaling pathways by SARM RAD140 in AR/ER+ breast cancer xenografts 11.57
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 11.56
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 11.55
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 11.52
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 11.52
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 11.47
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 11.45
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 11.42
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 11.37
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 11.32
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 11.05
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator [RNA-seq] 10.95
Polycomb- and Methylation-Independent Roles of EZH2 as a Transcription Activator 10.95
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 10.92
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 10.92
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 10.83
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 10.73
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 10.72
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 10.67
Expression by CD133+ cells isolated from the adult human exocrine pancreas 10.66
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 10.65
Effects of rFVIIIFc on human macrophages 10.61
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 10.53
A549 cells and MSR-A549 cells 10.53
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 10.53
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 10.43
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 10.4
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 10.19
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 10.09
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 10.08
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 10.04
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 10.01
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 10.01
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 9.97
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 9.88
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 9.84
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 9.78
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 9.71
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 9.55
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 9.55
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 9.54
HNRNPL and its RNA Targets in Prostate Cancer 9.54
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 9.54
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 9.5
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 9.49
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 9.44
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 9.44
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 9.39
Hypoxic transcriptome of SQ20B human head and neck cancer cells 9.36
The circadian transcriptional landscape in primary human mammary epithelial cells 9.35
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 9.3
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes 9.27
POU2AF1 Functions in the Human Airway Epithelium to Regulate Expression of Host Defense Genes [RNA-Seq] 9.27
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 9.24
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 9.24
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 9.2
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 9.2
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 9.19
mRNA-Seq profiling of human developing kidney 9.1
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 9.06
CD74 role in transcription regulation 9.05
CD74 role in transcription regulation [RNA-seq] 9.05
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 9.01
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 8.93
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 8.93
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 8.92
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 8.81
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 8.76
GATA3-mediated chromatin reprogramming in breast cancer cells 8.76
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 8.64
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 8.64
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 8.62
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 8.54
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 8.54
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 8.54
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 8.47
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 8.44
nELAVL HITS-CLIP in Alzheimer's Disease patients 8.41
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 8.39
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 8.3
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 8.3
Transcriptome analysis of kidney organoids 8.28
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 8.22
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 8.17
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 8.16
RNA-seq of MCF10A cells and CAF 8.15
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 8.13
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 8.13
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 8.12
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 8.08
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 8.06
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 8.05
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 8.03
Integrin signaling regulates YAP/TAZ to control skin homeostasis 7.99
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 7.98
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 7.93
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 7.81
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 7.66
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 7.62
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 7.58
RNA-seq analyses of human prostate cancer cells 7.52
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 7.52
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.47
RNAseq of IL-36 stimulated primary human keratinocytes 7.32
RNA-seq melanoma 7.32
CD73 knockdown effect in pancreatic cancer cell lines 7.26
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 7.15
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 7.15
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 7.14
Transcriptome of Stabilin-1 siRNA transfected human monocytes 7.14
JunB control of keratinocyte-mediated inflammation [RNA-seq] 7.13
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 7.13
Human optic chiasm from healthy controls and multiple sclerosis patients 7.13
Multiple sclerosis and EAE 7.13
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 7.09
METTL3 promotes translation in human cancer cells 7.05
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 7.01
Genome-wide functional assessment of enhancer activities in the human genome 7.0
High-Throughput Kinetic Analysis of Fractional Killing 6.99
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 6.97
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.96
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 6.95
SETBP1-WT and SETBP1-G870S epigenetic landscapes 6.94
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 6.94
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 6.91
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 6.91
Transcriptome analysis upon C6orf203 silencing 6.87
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.85
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 6.8
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 6.8
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 6.78
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 6.76
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.76
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 6.73
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 6.73
Nutritional control of protein translation 6.71
Primate transcript and protein expression levels evolve under compensatory selection pressures 6.69
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 6.63
Ro60-knockout cells 6.63
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 6.62
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.56
Landscape of H3K4me3 in human CD19 cells 6.49
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 6.44
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.43
The evolution of N6-methyladenosine in primates 6.42
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 6.41
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 6.41
Overexpression and knockdown experiment for circCSNK1G3 6.33
The conserved transcriptional landscapes in human spermatogenesis 6.31
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 6.3
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 6.27
Transcriptome wide analysis of classically and alternatively activated macrophages 6.22
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 6.2
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.15
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 6.14
RNA sequencing of human mammary epithelial cells 6.08
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 6.08
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 6.01
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 5.97
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 5.89
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 5.79
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 5.7
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 5.65
PTHrP overexpression in MCF7 cells 5.6
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 5.57
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 5.57
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 5.56
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 5.48
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 5.48
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 5.39
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 5.31
STX4 Over-Expression in Human islets 5.26
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 5.23
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 5.08
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 5.07
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 5.06
Endometrial transcriptome and PGR cistrome in cycling fertile women 5.06
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 5.06
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 5.05
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.04
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 4.98
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 4.96
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 4.93
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 4.88
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 4.88
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 4.8
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 4.72
Primary Human B-cell Temporal Response to CD40L Stimulation 4.7
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 4.7
CHD1 regulates cell fate determination by activation of differentiation-induced genes 4.57
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 4.54
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 4.52
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 4.52
RNA-Seq in PWS iPSC-derived neurons 4.47
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 4.4
Changes in human endometrial gland transcriptome over the window of implantation 4.37
Global epigenomic reconfiguration during mammalian brain development 4.37
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 4.34
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.34
Transcriptome analysis of peripheral blood monocytes 4.29
RNA seq analysis of human Fetal and adult derived Enterospheres 4.28
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 4.28
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 4.28
A Basal Stem Cell Signature Identifies Aggressive Prostate Cancer Phenotypes 4.27
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 4.24
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 4.24
Gene expression analysis of human hepatocellular cancers 4.18
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 4.14
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 4.12
Gene expression profile of human placenta from T. Cruzi infected mothers 4.11
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 4.02
A novel target of EZH1/2 for treatment of mantle cell lymphoma 3.97
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 3.95
RNA-seq of SCLC PDX models treated with EP 3.94
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 3.89
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.88
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 3.88
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 3.86
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 3.86
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 3.86
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.83
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 3.83
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 3.82
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 3.77
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 3.73
Gene expression profiling in metabolically heterogeneous human lung tumors 3.72
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 3.71
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 3.69
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 3.66
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 3.63
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 3.61
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 3.58
Transcriptome of human white and brown adipose tissue biopsies 3.45
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 3.27
Transcriptome analysis reveals differential splicing events in IPF lung tissue 3.23
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 3.23
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 3.23
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.13
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.13
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 3.13
Direct Isolation and Characterization of Human Nephron Progenitors. 3.07
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 3.03
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 3.03
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 3.01
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.87
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 2.86
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.85
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 2.85
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 2.85
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 2.84
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 2.84
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.78
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.75
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 2.67
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.64
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.64
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 2.62
Global gene expression profile of dasatinib-resistant RCH-ACV cells 2.6
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 2.51
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 2.49
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 2.43
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 2.43
Human islets of varying quality: the good, the (not so) bad and the ugly 2.42
RNAseq of Breast cancer PDX samples 2.42
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 2.41
Persistence of stem cell metabolism in cancers as a failure of differentiation 2.38
RNA sequencing analysis of selumetinib-resistant CRC cells lines 2.36
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  2.34
Evaluating pre-clinical models for studying NASH driven HCC. 2.3
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 2.29
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 2.27
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.27
Loss of endometrial plasticity in recurrent pregnancy loss 2.23
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 2.23
RNAseq in Alzheimer's Disease patients 2.22
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.22
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 2.21
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 2.21
Epigenome regulation during epidermal lineage commitment [RNA-seq] 2.19
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.17
Fusion discovery in breast cancer cell line 2.14
ML29755 RNA-seq data 2.12
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 2.11
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 2.11
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.09
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 2.08
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 2.07
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 2.03
Leucegene: ALL sequencing 1.96
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.96
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 1.95
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 1.94
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 1.91
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.9
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.86
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 1.84
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 1.8
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 1.8
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 1.77
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 1.77
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 1.73
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 1.72
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 1.68
Hepatic transcriptome of pediatric hepatoblastoma. 1.6
Alagille_Nodder 1.55
RNA Seq of Alagille liver biopsies 1.55
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.52
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.52
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.46
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 1.46
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 1.45
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 1.36
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.34
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 1.34
Zone dependent distinctive gene expression profile of the normal human liver tissue 1.33
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.31
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.29
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 1.29
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 1.26
Epigenome regulation during epidermal lineage commitment 1.18
Transcriptomic analysis of human macrophages in 3D 1.18
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 1.18
Gene expression of collecting duct carcinoma of the kidney 1.17
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 1.09
Gene expression activation in CLL mediated by MSCs contact 1.05
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 0.78
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 0.77
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 0.76
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.71
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 0.68
Differences in miRNA Detection Levels are Technology and Sequence Dependent 0.67
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 0.67
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.64
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.64
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.64
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.64
RNAseq analysis of ruxolitinib treated breast cancers 0.63
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.61
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.59
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.58
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.51
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 0.5
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.45
Specific molecular signatures underlie response to decitabine in CMML 0.45
An optimization system for isolating and sequencing of single human colon cancer cells 0.43
Engineering Patient-Specific Tissue Implants 0.42
MCF-7 as a model for functional analysis of breast cancer risk variants 0.42
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.39
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 0.37
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 0.37
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.36
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.35
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 0.34
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.34
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 0.33
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.32
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.31
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.28
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.28
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.27
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 0.25
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.25
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.24
Deep RNA sequencing of the human placental transcriptome 0.23
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.15
The effect of Abl kinases on non-small cell carcinoma global transcriptome 0.14
Identification of expressed and conserved human non-coding RNAs 0.12
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.07
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.06
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.06
Total RNA-Seq data from leukemic patients with complex structural variants 0.06
TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation